Women in Science Spotlight: Annette Bakker, PhD, on Innovation and Real-World Impact for Patients

The Children's Tumor Foundation (CTF) was recently featured in Healio in an article titled "Annette Bakker, PhD, on Rare Disease Research and 'Real Solutions' for Treating Patients," which highlights Dr. Bakker's journey as a scientist, leader, and advocate for patients with rare diseases.

In the interview, CTF CEO Annette Bakker reflects on her career path-from imaging labs in Belgium to senior leadership roles across Europe and the U.S.-and how those experiences shaped her commitment to bringing real solutions to patients. She describes the Foundation's bold approach to accelerating treatments, including its role in helping advance a shelved Pfizer compound, together with Springworks Therapeutics, into an FDA-approved treatment for adults and children with inoperable NF1 plexiform neurofibromas.

Beyond science and strategy: Dr. Bakker offers advice for women in medicine and research - and also equally valuable for anyone forging a career path. She emphasizes confidence, collaboration, and courage, reminding readers that "Nothing is irreversible," and encouraging the next generation to embrace risk-taking in pursuit of meaningful change for patients and families.

Read the full article here: Healio - Annette Bakker, PhD, on Rare Disease Research and 'Real Solutions' for Treating Patients

[Link]